Institutional Fund
Ally Bridge Group (Ny) LLC
New York, NYCIK 18229475 filings on record
Portfolio Value
$100.66M
Q1 2026
Holdings
21
Reported positions
New Buys
10
Opened this quarter
QoQ Change
+59.8%
from $63.00M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Praxis Precision Medicines I10.5%
- Minerva Neurosciences Inc9.9%
- Soleno Therapeutics Inc6.7%
- Ovid Therapeutics Inc6.2%
- Compass Pathways PLC5.7%
- Tarsus Pharmaceuticals Inc5.6%
- Other55.3%
Portfolio Holdings
21 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 32.8K | $10.57M | 10.5% | +12.9K | Added |
| 2 | Minerva Neurosciences Inc | 1.66M | $9.97M | 9.9% | 0 | Held |
| 3 | Soleno Therapeutics Inc | 200.0K | $6.70M | 6.7% | +32.0K | Added |
| 4 | Ovid Therapeutics Inc | 2.82M | $6.26M | 6.2% | +1.03M | Added |
| 5 | Compass Pathways PLC | 1.04M | $5.78M | 5.7% | +1.04M | New |
| 6 | Tarsus Pharmaceuticals Inc | 80.9K | $5.67M | 5.6% | +80.9K | New |
| 7 | Solid Biosciences Inc | 767.0K | $5.52M | 5.5% | +353.3K | Added |
| 8 | Promis Neurosciences Inc | 414.2K | $5.26M | 5.2% | +164.9K | Added |
| 9 | Edgewise Therapeutics Inc | 161.0K | $5.07M | 5.0% | −34.0K | Reduced |
| 10 | Eupraxia Pharmaceuticals Inc | 660.4K | $4.78M | 4.7% | +262.5K | Added |
11 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio